Patent: 6,306,609
✉ Email this page to a colleague
Summary for Patent: 6,306,609
Title: | Methods for the detection of nitric oxide in fluid media |
Abstract: | In accordance with the present invention, there are provided articles for use in non-invasive measurements of nitric oxide levels in a variety of fluid media, e.g., in mammalian body fluids. Articles according to the present invention comprise a nitric oxide trapping agent contained within a vessel, wherein the vessel comprises a semi-permeable membrane. Nitric oxide diffuses through the semi-permeable membrane and is trapped therein for subsequent quantitative analysis. Articles of the present invention are particularly useful in selectively detecting nitric oxide in the presence of other NO.sub.x species. |
Inventor(s): | Lai; Ching-San (Encinitas, CA) |
Assignee: | Medinox, Inc. (San Diego, CA) MCW Research Foundation, Inc. (Milwaukee, WI) |
Application Number: | 09/274,718 |
Patent Claims: | see list of patent claims |
Details for Patent 6,306,609
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | ZOSTAVAX | zoster vaccine live | For Injection | 125123 | 05/25/2006 | ⤷ Try a Trial | 2016-11-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |